The total pharmaceutical sales in Sweden experienced moderate fluctuations from 2013 to 2023, starting at $5.58 billion in 2013 and standing at $5.97 billion in 2023. The year-on-year variation highlighted a mix of declines and growths, with significant drops in 2015 (-12.75%) and 2022 (-9.03%), and notable increases in 2020 (6.58%) and 2021 (10.32%). The Compound Annual Growth Rate (CAGR) over the last five years (2018-2023) was 1.63%, indicating relatively stable growth.
Future trends to watch for include:
• Continual growth in pharmaceutical sales, with forecasts suggesting a value of $6.43 billion by 2028.
• A forecasted 5-year CAGR of 1.17%, which implies steady, albeit modest, annual growth.
• Increased innovation in healthcare, driven by technological advancements and an aging population, which may further stimulate the pharmaceutical market.
